549 related articles for article (PubMed ID: 28747521)
1. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
2. An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.
Zheng MQ; Kim SJ; Holden D; Lin SF; Need A; Rash K; Barth V; Mitch C; Navarro A; Kapinos M; Maloney K; Ropchan J; Carson RE; Huang Y
J Nucl Med; 2014 Jul; 55(7):1185-91. PubMed ID: 24854795
[TBL] [Abstract][Full Text] [Related]
3. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
[TBL] [Abstract][Full Text] [Related]
4. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vivo evaluation of [
Li S; Cai Z; Zhang W; Holden D; Lin SF; Finnema SJ; Shirali A; Ropchan J; Carre S; Mercier J; Carson RE; Nabulsi N; Huang Y
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1952-1965. PubMed ID: 31175396
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.
Zheng MQ; Nabulsi N; Kim SJ; Tomasi G; Lin SF; Mitch C; Quimby S; Barth V; Rash K; Masters J; Navarro A; Seest E; Morris ED; Carson RE; Huang Y
J Nucl Med; 2013 Mar; 54(3):455-63. PubMed ID: 23353688
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors.
Cai Z; Li S; Pracitto R; Navarro A; Shirali A; Ropchan J; Huang Y
ACS Chem Neurosci; 2017 Jan; 8(1):12-16. PubMed ID: 27741398
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
10. N-[
Schmitt S; Delamare J; Tirel O; Fillesoye F; Dhilly M; Perrio C
Nucl Med Biol; 2017 Jan; 44():50-61. PubMed ID: 27821345
[TBL] [Abstract][Full Text] [Related]
11. Kinetic Modeling and Test-Retest Reproducibility of
Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
[TBL] [Abstract][Full Text] [Related]
12. The Search for a Subtype-Selective PET Imaging Agent for the GABA
Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
[TBL] [Abstract][Full Text] [Related]
13. A Novel
Baum E; Zhang W; Li S; Cai Z; Holden D; Huang Y
ACS Chem Neurosci; 2019 May; 10(5):2450-2458. PubMed ID: 30689943
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of
Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
[TBL] [Abstract][Full Text] [Related]
15. Characterization in nonhuman primates of (R)-[
Zheng M; Ahmed H; Smart K; Xu Y; Holden D; Kapinos M; Felchner Z; Haider A; Tamagnan G; Carson RE; Huang Y; Ametamey SM
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2153-2162. PubMed ID: 35107627
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
18. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
[TBL] [Abstract][Full Text] [Related]
19. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
[TBL] [Abstract][Full Text] [Related]
20. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
